ICE Canola Midday: Waiting on two USDA reports
WINNIPEG, Manitoba--Intercontinental Exchange canola futures remained lower at mid-session Thursday, but they came away from the double-digit declines that marked this week.
A trader said canola, as with other commodities was consolidating ahead of two major reports from the United States Department of Agriculture: the prospective plantings and grain stocks as of Mar. 1.
They are scheduled to be published at 12 pm ET and are expected to have an affect on the markets, especially the plantings report.
The trader also noted "People who are ginger in the market and easily turn to the long side of things when the market goes up...they just decided to unwind those positions and take profits."
Pressure on canola continued to be felt from declines in the Chicago soy complex, European rapeseed, and Malaysian palm oil.
Upticks in global crude oil prices were limiting the losses in the oilseeds.
The markets will be closed tomorrow for Good Friday.
The Canadian dollar was higher late Thursday morning with the loonie climbing to 73.84 U.S. cents compared to Wednesday's close of 73.68.
Approximately 21,750 canola contracts were traded as of 11:37 a.m. ET, with prices in Canadian dollars per metric ton:
Canola Price Change May 622.20 dn 5.00 Jul 631.50 dn 5.60 Nov 639.60 dn 5.70 Jan 647.70 dn 4.70
Source: Commodity News Service Canada, news@marketsfarm.com
(END) Dow Jones Newswires
March 28, 2024 12:09 ET (16:09 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth